OMX Ventures is a venture capital firm focused on investing in a new era of bioengineering and its application for better tools, medicines, foods, industrial products, and more. We specialize in early-stage investments at the intersection of biology, big data, and AI, with a focus on therapeutics, bio tools, diagnostics, and synthetic biology platforms. We aim to help founders build strong teams, overcome key technical challenges in their first two years of operations, and grow into successful commercial enterprises. Before founding OMX, our partners invested early in successful biotech companies like 10X Genomics (TXG), Twist Bioscience (TWST), Ginkgo Bioworks (DNA), and QuantaLife (now part of Bio-Rad - BIO).
Contact us: info@omx.vc
Company Details
- Employees
- 16
- Address
- Chicago, Il, Us
- Industry
- Investment Management
- NAICS
-
Other Financial Investment ActivitiesPortfolio ManagementAll Other Financial Investment ActivitiesTrust, Fiduciary, and Custody ActivitiesMiscellaneous Financial Investment Activities
- Website
- https://www.omx.vc/
- HQ
- Chicago, IL
Omx Ventures Questions
Omx Ventures's website is https://www.omx.vc/
Omx Ventures's LinkedIn profile is https://www.linkedin.com/company/omx-ventures
Omx Ventures has
16 employees.
View email and phone details for 16
employees at Omx Ventures.
Omx Ventures's industry is
Investment Management
Omx Ventures's top competitors are
Paladin Capital Group,
Fine Structure Ventures,
Ahren Innovation Capital,
Pangea Bio,
Transform Vc,
Osage University Partners (Oup),
General Inception,
Wave - Women's Association Of Venture & Equity,
+nd Capital,
Constructive Bio.
Omx Ventures's categories are Investment Management
